Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABTNASDAQ • USD
0.21 USD
↘ 0.03 (11.30%)AT CLOSE (03:59 PM EST)
0.21
↘ 0.00 (0.89%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
0.21
↘ 0.00 (0.89%)
🔴Market: CLOSED

LABT is currently priced at $0.21. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest LABT is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 19, 2026.

Open?$0.23
High?$0.24
Low?$0.20
Prev. Close?$0.24
Volume?627.1K
Avg. Volume?30.1M
VWAP?$0.22
Rel. Volume?0.02x
Bid / Ask
Bid?$0.21 × 1.3K
Ask?$0.21 × 700
Spread?$0.00
Midpoint?$0.21
Valuation & Ratios
Market Cap?497.6K
Shares Out?N/A
Float?9.4M
Float %?65.8%
P/E Ratio?N/A
P/B Ratio?0.17
EPS?-$3.67
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
Employees
N/A
Market Cap
568.7K
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-04-23
Address
8031 COOPER CREEK BLVD.
UNIVERSITY PARK, FL 34201
Phone: (941) 225-2515
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?1.62%Low
Short Interest?152.9K
Days to Cover?1.0
Free Float9.4M
Avg Daily Volume6.8M
Settlement Date2026-10-30
Financial Health
Current Ratio?5.22Strong
Quick Ratio?5.22Strong
Cash Ratio?4.19Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.17CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-297.7%WEAK▾
ROA?
S&P
3
-242.0%WEAK▾
Cash Flow & Enterprise
FCF?$-4324904
Enterprise Value?$-2326002
Fundamentals ratios updated end of day